99mTc-DTPA SPECT/CT眼眶显像定量评估Graves眼病活动度的可行性研究
本研究评估四种SPECT/CT定量指标在Graves眼病(GO)眼外肌炎症活动度评估中的效用。活动期GO组所有指标的眼外肌摄取均显著高于非活动期和对照组(均P<0.001),非活动期与对照组间无显著差异;所有定量参数与临床活动度评分(CAS)呈显著正相关(均P<0.001);ROC分析显示SUVmean诊断效能最优(AUC=0.887)。基于CT的三维VOI勾画参数(SUVmean-3D和SUVmax-3D)较传统方法更可靠。
要点
- 眼眶99mTc-DTPA SPECT/CT定量指标可客观区分活动期与非活动期GO。
- 所有定量参数与CAS显著正相关,SUVmean诊断效能最优(AUC=0.887)。
- 基于CT三维VOI勾画的参数(SUVmean-3D、SUVmax-3D)可靠性优于传统方法。
核心结论
- 眼眶99mTc-DTPA SPECT/CT定量指标,尤其是SUVmean-3D,可有效量化GO眼外肌炎症活动度。
研究设计与样本
- 本研究为可行性研究,评估四种SPECT/CT定量指标在GO眼外肌炎症活动度评估中的效用,比较活动期GO、非活动期GO和对照组三组。
主要发现
- 活动期GO组四种指标的眼外肌摄取均显著高于非活动期和对照组(均P<0.001),非活动期与对照组间无显著差异。
- 所有定量参数与CAS呈显著正相关(均P<0.001)。
- ROC分析确认所有指标均可有效区分活动期与非活动期GO,SUVmean诊断效能最优(AUC=0.887)。
关键数值与推荐
- SUVmean区分活动期与非活动期GO的AUC为0.887。
- 活动期GO组所有四种指标的眼外肌摄取均显著高于非活动期和对照组(均P<0.001)。
- 所有定量参数与CAS均呈显著正相关(均P<0.001)。
临床怎么用
- 这些定量指标可为GO严重度提供客观量化工具,并用于随访中监测疾病变化。
- 该能力对监测治疗反应、指导治疗决策及作为临床试验潜在终点具有重要价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Graves' ophthalmopathy (GO) is a challenging autoimmune manifestation of Graves' disease, whose management relies on accurate assessment of inflammatory activity in the extraocular muscles (EOMs). The Clinical Activity Score (CAS), the current gold standard for assessing disease activity, is based on subjective clinical signs. Consequently, objective imaging biomarkers are urgently needed as a complement orbital 99mTc-DTPA SPECT/CT imaging holds potential, but its quantitative methodology lacks standardization. This study aimed to evaluate the utility of four SPECT/CT-derived quantitative indices for quantifying EOM inflammatory activity in GO. RESULTS: Group Differences: EOM uptake values for all four indices were significantly higher in the active GO group than in both the inactive and control groups (all P < 0.001). No significant differences were found between the inactive and control groups. CLINICAL CORRELATION: All quantitative parameters showed significant positive correlations with the CAS (all p < 0.001). DIAGNOSTIC PERFORMANCE: ROC curve analysis confirmed that all indices effectively differentiated active from inactive GO, with SUVmean yielding the superior diagnostic efficacy (AUC = 0.887). CONCLUSIONS: In summary, this study confirms that quantitative indices from orbital 99mTc-DTPA SPECT/CT, particularly SUVmean-3D, effectively quantify EOMs inflammatory activity in GO. Parameters derived using CT-based 3D VOI delineation (SUVmean-3D and SUVmax-3D) demonstrated superior reliability over traditional methods. Among all indices, SUVmean-3D demonstrated superior diagnostic efficacy (AUC = 0.887) for differentiating active from inactive disease. These indices provide an objective tool for quantifying GO severity and monitoring disease changes during patient follow-up. This capability is vital for monitoring treatment response, guiding therapeutic decisions, and serving as a potential endpoint in clinical trials.
引用
- Li Y, Cheng R, Yang Z, et al. Quantitative assessment of graves' ophthalmopathy activity using 99mTc-DTPA SPECT/CT orbital imaging: a feasibility study with multiple indicators. EJNMMI Res. 2026. PMID: 41582113. doi:10.1186/s13550-025-01360-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。